01066 WEIGAO GROUP
- 5.100
- +0.050+0.99%
WEIGAO GROUP News
These 4 Measures Indicate That Shandong Weigao Group Medical Polymer (HKG:1066) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
From the pain of collection to the decline in net profit distribution, going overseas or becoming the only way out for orthopedic consumables?
As the fourth batch of high-value consumables collected last year directly targeted artificial lenses and high-value orthopedic sports medicine consumables, almost all high-value consumables in the orthopedic field have already been collected. Even if this collection is “mild” compared to the previous three rounds of overall price cuts, it will inevitably have a negative impact on the performance of leading domestic companies in the short term, and there is a certain relationship with the imbalance in the companies' “price for volume” game. Judging from the 2023 financial reports disclosed by many industry companies, the traditional logic of “price for volume” collection has not been fully demonstrated. It is not that the more companies that win the bid, the better their performance growth. On the contrary, the increase in sales brought about by harvesting does not seem to offset the product
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Shandong Weigao Group Medical Polymer Co (OtherSHWGF) and Cormedix (CRMD)
Bank Rating | DBS: Lowering the target price of Weigao shares to HK$6.4 to maintain a “buy” rating
According to a research report published by DBS, the profit of Weigao shares fell 27.6% year-on-year in 2023, in line with the profit announcement issued earlier, mainly due to falling prices of medical devices and consumables products in different businesses due to volume procurement policies, and no longer selling products related to the epidemic. Accordingly, DBS lowered Weigao's profit forecast for 2024 to 2025 by 32% and 35%, and the target price was lowered from HK$11.6 to HK$6.4. However, the bank pointed out that Weigao's stock price has fallen 37% a few years ago. The expected negative factors are fully reflected in the stock price performance. It is optimistic that the company is the leading supplier of medical consumables and pharmaceutical packaging in China
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
With its stock down 36% over the past three months, it is easy to disregard Shandong Weigao Group Medical Polymer (HKG:1066). But if you pay close attention, you might find that its key financial in
Changes in Hong Kong stocks | Medical device stocks rose higher in the afternoon, and mining affected the industry's high-value consumables business growth expectations this year generally improved
Medical device stocks rose in the afternoon. As of press release, Weigao shares (01066) rose 9.25% to HK$5.08; Elken Healthcare (01,789) rose 4.35% to HK$4.08; and minimally invasive robot-B (02252) rose 1.91% to HK$13.88.
Weigao Group Logs 28% Decline in 2023 Profit
Shandong Weigao Group Medical Polymer (HKG:1066) recorded a 27.6% decline in attributable profit for the year ended Dec. 31, 2023, to 2 billion yuan from 2.76 billion yuan in 2022, a Tuesday filing on
Weigao shares (01066) will pay a final dividend of $0.0943 per share on July 12
Weigao Co., Ltd. (01066) announced that the company will pay a final dividend per share on July 12, 2024...
Weigao shares (01066.HK): 2.02 billion yuan in 2023, a year-on-year decrease of 27.6%
On March 26, GLONGHUI Co., Ltd. (01066.HK) announced that for the year ended December 31, 2023, it recorded revenue of approximately RMB 13.229 billion, down 3.8% from the previous year. Net profit attributable to company owners was approximately RMB 2.02 billion, down 27.6% from the previous year. Net profit attributable to company owners excluding special projects was approximately RMB 1,982 million, down 28.8% from the previous year's comparable figure. The directors proposed a final dividend of RMB 0.0943 per share.
WEIGAO GROUP: ANNOUNCEMENT OF RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Weigao Co., Ltd. (01066): Gong Jianbo resigns as a director of the 3rd board of directors of Weigao Orthopedics (688161.SH)
Weigao Co., Ltd. (01066) issued an announcement that Shandong Weigao Orthopedic Materials Co., Ltd. (hereinafter referred to as the “Company”) (...
Shandong Weigao Group Faces Earnings Hit on Slower Growth of High-Margin Segments -- Market Talk
0543 GMT - Shandong Weigao Group Medical Polymer faces earnings hit from likely slower growth of its high-margin segments such as orthopedic products and pharma packaging, Nomura analysts say in a res
Shandong Weigao Group Medical Polymer Target Price Lowered to HK$8.45 From HK$9.91 by Nomura>1066.HK
Shandong Weigao Group Medical Polymer Target Price Lowered to HK$8.45 From HK$9.91 by Nomura>1066.HK
Shareholders in Shandong Weigao Group Medical Polymer (HKG:1066) Are in the Red If They Invested Three Years Ago
The truth is that if you invest for long enough, you're going to end up with some losing stocks. But the long term shareholders of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) hav
Weigao Co., Ltd. (01066): Weigao Orthopedic (688161.SH) has repurchased a total of 1,597,300 A shares
Weigao Orthopedic Clinic (688161.SH), affiliated with Weigao Co., Ltd. (01066), issued an announcement as of 2024 2...
Weigao Co., Ltd. (01066) released a quick report on the annual results of Weigao Orthopedics (688161.SH). Net profit to mother was 112 million yuan, a year-on-year decrease of 81.29%
Weigao Co., Ltd. (01066) released Shandong Weigao Orthopedic Materials Co., Ltd. (688161.SH) as of 2...
WEIGAO GROUP: Notice of Board Meeting
Risks Still Elevated At These Prices As Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Dive 25%
To the annoyance of some shareholders, Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) shares are down a considerable 25% in the last month, which continues a horrid run for the compa
Weigao shares (01066) fell 4.90% and now reports 4.730 yuan, a 52-week low
As of 11:06, Weigao shares (01066) are down 4.90% from yesterday's closing price and now reports a 52-week low of $4.730; the trading volume is 4.95542 million shares, with a turnover of HK$24.2814 million.
Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Amongst other things, we'll want to see two things; firstly,
Analysis
Price Target
No Data
